Bio Pharma Dive
DECEMBER 8, 2021
Passage Bio and the University of Pennsylvania's Gene Therapy Program said they have begun preclinical research aimed at simultaneously developing multiple approaches to treating Huntington's.
World of DTC Marketing
DECEMBER 8, 2021
LEAD-IN- Recent data confirms that health care professionals are using the Internet more and spending less time with drug company reps. How much should you spend on an HCP portal, and how do you measure its success? One of the first questions I often get from potential clients is, “how much does a good HCP website cost?” There is no one answer to that question.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 8, 2021
The payment resolves the government's claims against Vyera and Phoenixus for their efforts to block competition to Daraprim, the toxoplasmosis drug Shkreli famously raised the price of by 4,000%.
XTalks
DECEMBER 8, 2021
B.T. Sweet, an Israeli food tech startup, recently unveiled a plant-based, one-to-one drop-in sugar substitute called Cambya. It can replace sugar in a multitude of applications in the chocolate and confectionary space, boasting the same levels of sweetness and body as real sugar. So, what is Cambya and what differentiates it from other sugar substitutes?
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
DECEMBER 8, 2021
Preliminary laboratory testing by Pfizer and partner BioNTech indicated three doses may protect against omicron as well as two doses versus the original coronavirus strain.
BioSpace
DECEMBER 8, 2021
Researchers published a study proving that SARS-CoV-2 infects human adipose or fat tissue to multiply and elicit an inflammatory response corresponding with severe COVID-19.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharma Times
DECEMBER 8, 2021
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully bypass vaccine protections.
pharmaphorum
DECEMBER 8, 2021
Preliminary study results from South Africa have suggested that antibodies stimulated by Pfizer and BioNTech’s Comirnaty are less effective against the new COVID-19 variant Omicron. A study by the African Health Research Institute (AHRI) has found that the less of immune protection was “extensive but incomplete,” meaning that some level of immunity was retained against the vaccine.
Pharma Times
DECEMBER 8, 2021
The Evra hormonal patch can be worn discreetly and according to Gedeon Richter UK Ltd, is over 99% effective at pregnancy prevention
pharmaphorum
DECEMBER 8, 2021
Personal relationships have been the dominant force in sales for generations but the pandemic has ripped up this conveyer belt of convenience. More than 60% of clinicians are happy to either connect solely via technology or via a hybrid arrangement and there is no going back. The pharmaceutical industry became stuck in a groove of letting doctor-rep relationships obscure the challenge of delivering complex information in perfectly pitched presentations.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
DECEMBER 8, 2021
AMES, Iowa – Methane, which produces more warming than other greenhouse gases and is the subject of newly announced U.S. emission restrictions, is hard to break down and keep out of the atmosphere. Credit: Photo by Christopher Gannon/Iowa State University AMES, Iowa – Methane, which produces more warming than other greenhouse gases and is the […].
pharmaphorum
DECEMBER 8, 2021
French digital health startup HypnoVR has completed a first-round financing, raising €4.5 million ($5.1 million) that will be used to roll out its virtual reality-based hypnosis therapies. The company has developed a an individually tailored immersive VR platform that it uses to deliver clinical hypnosis techniques to alleviate chronic pain, anxiety and discomfort during medical procedures like surgery.
BioSpace
DECEMBER 8, 2021
Instead of letting LinkedIn slide to the bottom of your to-do list day after day, block off an hour on your calendar once a week to create a post and engage with your connections.
pharmaphorum
DECEMBER 8, 2021
China’s Shanghai Henlius Biotech says its experimental PD-1 inhibitor serplulimab has extended survival when added to chemotherapy in a phase 3 trial as first-line therapy for extensive stage small cell lung cancer (ES-SCLC), setting up regulatory filings. The trial compared serplulimab (formerly HLX10) plus carboplatin and etoposide chemotherapy in previously untreated patients with ES-SCLC , and showed a higher overall survival than chemo alone, according to the company.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
DECEMBER 8, 2021
MINNEAPOLIS / ST. PAUL (12/07/2021) — If you ever wanted to be an astronomer, now is your chance. A new citizen science project, led by researchers at the University of Minnesota with support from NASA, allows volunteers to play an important role in learning more about the Sun by using their personal computers. Credit: NASA MINNEAPOLIS […].
NY Times
DECEMBER 8, 2021
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
Scienmag
DECEMBER 8, 2021
We are one of the most medicated generations of humans to live on our planet. Cardiometabolic diseases like type 2 diabetes, obesity, and coronary artery disease continue to increase in prevalence and together constitute the highest cause of mortality worldwide. Affected people often have to take multiple daily medications for months or even years. Credit: […].
BioSpace
DECEMBER 8, 2021
1E Therapeutics announced $120 million seed funding, a remarkable feat for an early-stage biotech company. The funding is the largest of its kind for an Israeli biotech company.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
DECEMBER 8, 2021
Debilitating cluster headaches commonly begin in childhood, but patients are not typically diagnosed until they are adults, according to research from The University of Texas Health Science Center at Houston (UTHealth Houston). Credit: Photo courtesy of UTHealth Houston Debilitating cluster headaches commonly begin in childhood, but patients are not typically diagnosed until they are adults, […].
BioSpace
DECEMBER 8, 2021
Researchers in China are busy developing several treatments, combining vaccines and drugs for COVID-19, as also working on monoclonal antibody treatments.
Scienmag
DECEMBER 8, 2021
HOUSTON, TEXAS – Schlumberger Inventor Ashers Partouche is the recipient of the 2022 Edith and Peter O’Donnell Award in Technology Innovation from TAMEST (The Academy of Medicine, Engineering and Science of Texas). He was chosen for the wellbore formation testing technology platform he helped develop, Ora, which is in use globally in the energy industry. […].
BioSpace
DECEMBER 8, 2021
Shares of Reata Pharmaceuticals have plunged nearly 40% in premarket trading after an FDA advisory panel recommended against the approval of its Alport syndrome disease treatment, bardoxolone.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
DECEMBER 8, 2021
PITTSBURGH, Dec. 8, 2021 – Men who contracted HIV in the early days of the HIV/AIDS pandemic harbored a greater relative abundance of pro-inflammatory vs. anti-inflammatory gut microbes before they became HIV-positive compared to their counterparts who remained HIV-negative, according to new research published today in the journal Microbiome. In addition, the men who progressed […].
BioSpace
DECEMBER 8, 2021
The holds were lifted by the FDA in July of 2020, but the company’s timeline had been severely set back by the miscalculation.
Scienmag
DECEMBER 8, 2021
A new paper in Cardiovascular Research, published by Oxford University Press, indicates that iron treatments may reduce heart attacks in patients experiencing kidney failure undergoing dialysis. Coronary artery disease is prevalent in patients with chronic kidney disease but how often heart attacks occur in patients on maintenance hemodialysis and the appropriate treatments to try to […].
BioSpace
DECEMBER 8, 2021
CSL Behring and uniQure announced that their etranacogene dezaparvovec hit the pre-specified primary endpoint in their Phase III clinical trial in severe to moderately severe hemophilia B.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
DECEMBER 8, 2021
Reef fish, such as emperors, tropical snappers and rockcods, help keep numbers of crown-of-thorns starfish in check on the Great Barrier Reef, according to a new study from the Australian Institute of Marine Science. Credit: Australian Institute of Marine Science Reef fish, such as emperors, tropical snappers and rockcods, help keep numbers of crown-of-thorns starfish […].
XTalks
DECEMBER 8, 2021
In this episode, Ayesha discussed statements from Moderna and Pfizer regarding Omicron and the need for new variant-specific boosters. Moderna’s CEO sparked concerns when he said the current vaccines likely won’t be effective against Omicron, while Pfizer’s CEO said vaccines for COVID-19 will likely be needed for many years. The editorial team discussed the impact of these comments as they were relatively premature given that not much is known about Omicron yet, such as its transmissibility and
Scienmag
DECEMBER 8, 2021
Encouraging interactions between people on opposite ends of the political spectrum may not be the best way to foster tolerance in a polarized nation. Credit: Proceedings of the National Academy of Sciences Encouraging interactions between people on opposite ends of the political spectrum may not be the best way to foster tolerance in a polarized […].
pharmaphorum
DECEMBER 8, 2021
pharmaphorum’s founder, Dr Paul Tunnah, talks with Debiopharm Innovation Fund’s CEO Tanja Dowe at Frontiers Health as part of his mini series of interviews from Frontiers Health. . Live from the conference in Milan, Tanja discusses how Debiopharm Innovation Fund concentrates on series A and series B investments, and recently released a report outlining what’s next for start-ups who’ve received series A funding.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
345 
Let's personalize your content